Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Observational Registry Evaluating Risk Stratification, Clinical Management Decisions, and Clinical Outcomes Following the Nodify Lung® Sequential Testing Strategy in Patients With Indeterminate Pulmonary Nodules

NCT07858552 is registered in ClinicalTrials.gov with Biodesix, Inc. as lead sponsor.

NCT NCT07858552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07858552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Observational Registry Evaluating Risk Stratification, Clinical Management Decisions, and Clinical Outcomes Following the Nodify Lung® Sequential Testing Strategy in Patients With Indeterminate Pulmonary Nodules
Lead sponsor
Biodesix, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2030
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

indeterminate pulmonary nodule